K36 Therapeutics Completes Dosing of First Cohort in PCCTC-Managed Phase 1 Clinical Trial of KTX-2001 in Prostate Cancer

Feb 5

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

PCCTC Investigators Showcase Groundbreaking Research at 2026 ASCO GU Symposium

PCCTC Investigators and Colleagues Highlight the Importance of Racial Diversity in Future Genomic Profiling and Clinical Trials Efforts (Nature)